Figure 3From: Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses Scatterplot of exposure against dose. A: The scatterplot of TP3076 Cmax. B: The scatterplot of TP3076 AUC. C: The scatterplot of TP3011 Cmax. D: The scatterplot of TP3011 AUC. E: The scatterplot of the sum of TP3076 and TP3011 Cmax. F: The scatterplot of the sum of TP3076 and TP3011 AUC.Back to article page